Skip to content
Review

[Immune Checkpoint Tim-3 Regulates Microglial Function in Alzheimer's Disease].

Aug 2026 · Brain and nerve = Shinkei kenkyu no shinpo · Vol 78 8, pp. 931-937 · 0 citations
Medicine

TL;DR

It is suggested that Tim-3 acts as a functional checkpoint that limits beneficial microglial responses in AD and that targeting Tim-3 may therefore represent a promising therapeutic strategy for reprogramming microglia and improving disease outcomes.

View source

Similar papers

Review Open access Sep 2026

Is there a role for B cells in Alzheimer's disease?

The phenotypic and functional alterations of B cells in AD are reviewed, integrating evidence from experimental models and human studies to evaluate whether B cells constitute an underappreciated component of the adaptive immune response in AD and whether they represent a compelling immunotherapeutic target.

Eva-Loren Charavner, S. Fillatreau, M. El Behi · 0 citations
Review Open access Aug 2026

Microglial dysfunction and NLRP3 inflammasome signaling in Alzheimer’s disease: mechanistic insights into neuroinflammation and neurodegeneration

Alzheimer's disease (AD) is a progressively debilitating neurodegenerative condition characterized by the accumulation of amyloid-β (Aβ), tau pathology, synaptopathy, and neuron loss. Recent studies suggest that Neuroinflammation is a critical part of the disease process rather than an accompanying feature of the menti...

Almas Meheboob Pathan · 0 citations
Review Aug 2026

The role of microglia glucose metabolism reprogramming in Alzheimer's disease treatment

This review systematically outlines the fundamental characteristics of microglial glucose metabolism and focuses on how the dynamic metabolic reprogramming it undergoes during AD progression regulates microglial immune behavior and inflammatory responses.

Qing-Yu Cao, Meng-Meng Shen, Yan Liu et al. · 0 citations
Review Sep 2026

Targeting cytokine-driven neuroinflammation in Alzheimer’s disease: mechanistic insights and pharmacological strategies

This review provides a comprehensive overview of cytokine-mediated neuroinflammation in Alzheimer's disease, focusing on the cellular sources of cytokine production within the brain, including microglia, astrocytes, neurons, and endothelial cells.

R. Wasim · 0 citations
Review Open access Sep 2026

IL-34 in neurological homeostasis and its multifaceted roles in central nervous system diseases

Interleukin-34 (IL-34), a ligand for the macrophage colony-stimulating factor receptor (CSF1R), plays an indispensable role in the development and homeostasis maintenance of the central nervous system (CNS). This review systematically outlines the core mechanisms by which the IL-34/CSF1R signaling axis regulates the de...

Ying Xin, You-Yang Liao, Xing Cao et al. · 0 citations
Review Open access Aug 2026

Microglia-mediated neuroinflammation in Alzheimer’s disease: mechanisms and emerging therapeutic targets

A “cellular state–pathological network–therapeutic window” framework is proposed and the roles of microglia in amyloid-β plaque seeding and compaction, NLRP3 inflammasome activation, mitochondrial DNA–cGAS–STING signaling, complement-mediated synaptic engulfment, and bidirectional microglia–tau feedback are systematica...

Lian-Jing Xu, Ying Zhang, Li Jiang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.